Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Direct Meds

Two GLP-1 desks, one scoreboard. We put CoreAge Rx and Direct Meds head-to-head on the published Brief Score — the same six factors, scored the same way, no pay-to-win placement.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 27 · Grade B−

Direct Meds

Visit Direct Meds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 82 on our six-factor Brief Score — The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

That doesn't make Direct Meds a bad call — it's best for readers who want a needle-free oral or sublingual route on either molecule and an all-inclusive price with no separate membership — and who are comfortable that the figures are company-stated rather than checkout-verified. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 on the board — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
80
Supply Reliability
95
80
Transparency
90
78
Access Breadth
93
84
Clinical Oversight
92
83
Track Record
88
78
CoreAge RxBrief Score 94 · 82Direct Meds

Price, coverage & the tracker

CoreAge RxDirect Meds
Brief Score94/100 (A)82/100 (B−)
Semaglutide$149/mo$179/mo
Tirzepatide$349/mo$224/mo
CoverageAll 50 statesNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.

Direct Meds: Company-stated rates unchanged this cycle — but we price these off the desk's own listings, not a live-verified checkout, so treat them as indicative.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.